FULGENT GENETICS, INC. (FLGT) Operating Margin
- Operating margin · 12 months: Value -37.75%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -37.75% | Operating income / revenue. Period ending 2026-06-30. $-122.28M ÷ $323.93M × 100 ≈ -37.75% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -122.28M USD | Operating Income (Loss) |
| Revenue | 323.93M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 56.76M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-122.28M | $323.93M | (m) | $56.76M | (m) | -37.75% |
| 2026-03-31 | $-105.92M | $320.35M | (m) | $55.69M | (m) | -33.07% |
| 2025-12-31 | $-91.10M | $322.67M | (m) | $53.91M | (m) | -28.23% |
| 2025-09-30 | $-70.99M | $315.55M | (m) | $51.85M | (m) | -22.50% |
| 2025-06-30 | $-72.72M | $303.22M | (m) | $49.77M | (m) | -23.98% |
| 2025-03-31 | $-71.92M | $292.45M | (m) | $49.78M | (m) | -24.59% |
| 2024-12-31 | $-73.92M | $283.47M | (m) | $48.82M | (m) | -26.08% |
| 2024-09-30 | $-208.90M | $277.76M | (m) | $48.66M | (m) | -75.21% |
| 2024-06-30 | $-191.61M | $290.70M | (m) | $46.89M | (m) | -65.91% |
| 2024-03-31 | $-192.50M | $287.53M | (m) | $43.09M | (m) | -66.95% |
| 2023-12-31 | $-195.53M | $289.21M | (m) | $41.44M | (m) | -67.61% |
| 2023-09-30 | $-80.96M | $286.41M | (m) | $38.00M | (m) | -28.27% |
| 2023-06-30 | $-80.82M | $307.38M | (m) | $35.49M | (m) | -26.29% |
| 2023-03-31 | $-48.23M | $364.87M | (m) | $32.70M | (m) | -13.22% |
| 2022-12-31 | $178.53M | $618.97M | (m) | $28.91M | (m) | 28.84% |
| 2022-09-30 | $365.94M | $802.93M | (m) | $27.86M | (m) | 45.58% |
| 2022-06-30 | $524.86M | $925.15M | (m) | $26.38M | (m) | 56.73% |
| 2022-03-31 | $610.96M | $953.42M | (m) | $24.79M | (m) | 64.08% |
| 2021-12-31 | $675.95M | $992.58M | (m) | $24.22M | (m) | 68.10% |
| 2021-09-30 | $751.00M | $1.04B | (m) | $21.33M | (m) | 72.50% |
| 2021-06-30 | $655.25M | $909.74M | (m) | $18.49M | (m) | 72.03% |
| 2021-03-31 | $558.99M | $773.39M | (m) | $15.02M | (m) | 72.28% |
| 2020-12-31 | $290.16M | $421.71M | (m) | $11.58M | (m) | 68.80% |
| 2020-09-30 | $63.84M | $135.12M | (m) | $8.80M | (m) | 47.25% |
| 2020-06-30 | $1.83M | $43.75M | (m) | $7.37M | (m) | 4.17% |
| 2020-03-31 | $-519.00K | $34.91M | (m) | $7.09M | (m) | -1.49% |
| 2019-12-31 | $-428.00K | $32.53M | $0.00 | $6.54M | (m) | -1.32% |
| 2019-09-30 | $-1.05M | $29.81M | (m) | $6.17M | (m) | -3.52% |
| 2019-06-30 | $-3.40M | $25.09M | (m) | $5.86M | (m) | -13.56% |
| 2019-03-31 | $-4.70M | $22.07M | (m) | $5.50M | (m) | -21.29% |
| 2018-12-31 | $-5.07M | $21.35M | $0.00 | $5.53M | (m) | -23.75% |
| 2018-09-30 | $-6.11M | $19.96M | (m) | $5.43M | (m) | -30.62% |
| 2018-06-30 | $-6.75M | $18.84M | (m) | $5.12M | (m) | -35.81% |
| 2018-03-31 | $-5.89M | $18.08M | (m) | $4.83M | (m) | -32.61% |
| 2017-12-31 | $-3.48M | $18.73M | (m) | $4.22M | (m) | -18.59% |
| 2017-09-30 | $-154.00K | $20.30M | (m) | $3.72M | (m) | -0.76% |
| 2017-06-30 | $632.00K | $20.81M | (m) | $4.11M | (m) | 3.04% |
| 2017-03-31 | $1.75M | $20.14M | (m) | $3.85M | (m) | 8.70% |
| 2016-12-31 | $918.00K | $18.28M | (m) | $3.56M | (m) | 5.02% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $-5.81M | $13.22M | (m) | $5.18M | (m) | -43.95% |
| 2016-03-31 | $-6.03M | $11.43M | (m) | $4.78M | (m) | -52.78% |
| 2015-12-31 | $-5.01M | $9.58M | (m) | $4.43M | (m) | -52.34% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-990.00K | $1.28M | (m) | $521.00K | (m) | -77.46% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |